Earnings Date
EPS
Quarterly Revenue
Annual Revenue (as of Sep 30)
Earnings Recap
Vanda Pharma (NASDAQ:VNDA) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Vanda Pharma missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.04.
Revenue was down $26.50 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 8.05% drop in the share price the next day.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Earnings History
Analyze the earnings history of Vanda Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/07/2024 | PM | VNDA | Q4 | $0.12 | — | — | — | $64.48M | — | — | — | Get Alert |
| 11/08/2023 | PM | VNDA | Q3 | $0.06 | -$0.04 | $0.00 | 100.00% | $65.32M | $44.50M | $38.81M | -12.78% | Get Alert |
| 07/27/2023 | PM | VNDA | Q2 | $0.05 | -$0.13 | $0.03 | 123.08% | $64.39M | $49.00M | $46.06M | -6.01% | Get Alert |
| 05/03/2023 | PM | VNDA | Q1 | -$0.11 | — | $0.06 | — | $60.19M | — | $62.50M | — | Get Alert |
| 02/08/2023 | PM | VNDA | Q4 | $0.12 | $0.08 | $0.12 | 50.00% | $68.02M | $67.60M | $64.48M | -4.61% | Get Alert |
| 11/02/2022 | PM | VNDA | Q3 | $0.14 | $0.09 | $0.06 | -33.33% | $70.09M | $71.00M | $65.32M | -8.00% | Get Alert |
| 08/03/2022 | PM | VNDA | Q2 | $0.17 | $0.11 | $0.05 | -54.55% | $67.90M | $67.00M | $64.39M | -3.90% | Get Alert |
| 05/05/2022 | PM | VNDA | Q1 | $0.15 | -$0.01 | -$0.11 | -1000.00% | $62.67M | $58.00M | $60.19M | 3.78% | Get Alert |
| 02/23/2022 | PM | VNDA | Q4 | $0.15 | $0.08 | $0.12 | 50.00% | $67.65M | $70.04M | $68.02M | -2.89% | Get Alert |
| 11/03/2021 | PM | VNDA | Q3 | $0.11 | $0.16 | $0.14 | -12.50% | $60.31M | $75.00M | $70.09M | -6.54% | Get Alert |
| 07/28/2021 | PM | VNDA | Q2 | $0.16 | $0.14 | $0.17 | 21.43% | $62.21M | $69.75M | $67.90M | -2.65% | Get Alert |
| 05/05/2021 | PM | VNDA | Q1 | $0.01 | $0.15 | $0.15 | 0.00% | $58.00M | $68.50M | $62.67M | -8.51% | Get Alert |
| 02/10/2021 | PM | VNDA | Q4 | $0.08 | $0.14 | $0.15 | 7.14% | $60.93M | $64.00M | $67.65M | 5.71% | Get Alert |
| 10/28/2020 | PM | VNDA | Q3 | $0.23 | $0.09 | $0.11 | 22.22% | $59.48M | $63.95M | $60.31M | -5.70% | Get Alert |
| 08/05/2020 | PM | VNDA | Q2 | $0.21 | — | $0.16 | — | $59.06M | $61.95M | $62.21M | 0.41% | Get Alert |
| 05/06/2020 | PM | VNDA | Q1 | $0.06 | — | $0.01 | — | $47.71M | $56.87M | $58.00M | 1.99% | Get Alert |
| 02/25/2020 | PM | VNDA | Q4 | $0.26 | $0.11 | $0.08 | -27.27% | $53.04M | $59.57M | $60.93M | 2.28% | Get Alert |
| 11/06/2019 | PM | VNDA | Q3 | $0.20 | $0.07 | $0.23 | 228.57% | $49.13M | $58.32M | $59.48M | 2.00% | Get Alert |
| 07/31/2019 | PM | VNDA | Q2 | $0.14 | — | $0.28 | — | $47.35M | $54.15M | $59.06M | 9.07% | Get Alert |
When is Vanda Pharma (NASDAQ:VNDA) reporting earnings?
Vanda Pharma (VNDA) is scheduled to report earnings on February 7, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.
What were the latest earnings per share (EPS) for Vanda Pharma (NASDAQ:VNDA)?
The Actual EPS was $0.00, which beat the estimate of $-0.04.
What were Vanda Pharma’s (NASDAQ:VNDA) revenues?
The Actual Revenue was $38.8M, which missed the estimate of $44.5M.
Browse earnings estimates, EPS, and revenue on all stocks.